Canagliflozin

Details

Files
Generic Name:
Canagliflozin
Project Status:
Withdrawn
Therapeutic Area:
Diabetes Mellitus, Type 2
Manufacturer:
Janssen Inc.
Brand Name:
Invokana
Project Line:
Reimbursement Review
Project Number:
SR0335-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Diabetes mellitus, type 2